Preclinical studies and drug combination of low-cost molecules for chagas disease

HIGHLIGHTS

• who: Elena Aguilera et al. from the Instituto Biolu00f3gica, Facultad Ciencias, Universidad la Repu00fablica, Montevideo, Uruguay have published the paper: Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease, in the Journal: Pharmaceuticals 2023, 16, x FOR PEER REVIEW of 18/Dec/2022
• what: The authors evaluate if a polypharmacological approach employing the compounds developed by the group , which have different mechanisms of action, could achieve better antiparasitic activity than when used in monotherapy. NMR Metabolomics Studies This technique for quantifying internal or excreted metabolites by 1 H-NMR, implemented in the . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.